Tender Notice for the Finished-Product Cold Storage Project of Minhai Biotechnology R&D and Production Building (R&D and Production Building Construction Project)

Release date:

2020-08-07

Author:

Source:


Abstract

I. Project Name: Minhai Biotechnology R&D and Production Building (R&D and Production Building Construction Project) – Finished‑Product Cold Storage Project II. Project Overview: The general cold storage facility for the Minhai Biotechnology R&D and Production Building (R&D and Production Building Construction Project), invested in and constructed by Beijing Minhai Biotechnology Co., Ltd., is located at No. 35 Simiao Road, Daxing Biomedical Industry Base. This project is primarily intended for the storage of finished vaccine products. Construction Scale: The basement has a total footprint of 380 m², with a room height of 3 meters. Construction Location: Basement of the R&D and Production Building Purpose: Used for storing vaccine products Compliance with Relevant Standards: 1. Cold Storage Design Code GB 50072-2010;

I. Project Name: Minhai Biotechnology R&D and Production Building (R&D and Production Building Construction Project) – Finished Goods Cold Storage System

II. Project Overview:

The standard cold storage facility for the Minhai Biotechnology R&D and Production Building (R&D and Production Building Construction Project), invested in and constructed by Beijing Minhai Biotechnology Co., Ltd., is located at No. 35 Simiao Road, Daxing Biomedical Industry Base. This project is primarily intended for the storage of finished vaccine products.

Construction scale: The total floor area of the basement is 380 m². 2 , The room height is 3 meters.

Construction Location: Basement of the R&D and Production Building

Purpose: For storing vaccine products.

Complies with regulatory requirements:

1. Cold Storage Design Code GB 50072-2010;

2. China GMP ( 2010 (Revised in [Year]) and its appendices;

    3 GEP Good Engineering Practice;

III. Scope of the Tender:

The scope of this tender is the general cold storage project for Minhai Bio’s R&D and Production Building (R&D and Production Building Construction Project).

IV. Registration Notes:

1. Participating entities must submit the following documents: the business license of the legal entity, qualification certificates, the safety production license, a certificate of the legal representative or a letter of authorization from the legal representative, and copies of identification documents—four sets in total, with all copies stamped with the official seal of the entity—and must indicate the company’s registered capital.

2. Participating entities must possess the relevant professional qualifications: Grade III qualification for mechanical and electrical installation, GC2 qualification for pressure piping, and demonstrated project experience (with each individual project valued at no less than RMB 3 million).

3. Registration requires the provision of a contact person and contact information from the submitting organization. The contact person must be the project leader or an designated business liaison, and a 12-month social security certificate must be submitted.

4. The tendering entity will review the qualification documents submitted by registered entities, giving priority to those with relevant project experience, and will conduct further communication and on-site inspections with the shortlisted candidates.

5. Beijing Minhai Biotechnology Co., Ltd. was established in 2004 and is a wholly owned subsidiary of Shenzhen Kangtai Biological Products Co., Ltd. (a publicly listed company). For more information, please visit the company’s website.

6. The company’s newly constructed facility includes a finished‑goods warehouse with an area of 3,000 m²; for this tender, the finished‑goods cold storage is designated as the benchmark.

V. Registration Address: Beijing Minhai Biotechnology Co., Ltd. (No. 35, Simiao Road, Bio‑Pharmaceutical Industry Base, Daxing District, Beijing). Contact Persons: Mr. Hao and Ms. Fang, New Project Department; Contact Numbers: 010-57864916, 010-57864911.

Electronic materials have been sent to the email address: wanghao@biominhai.com

VI. Registration Deadline: 5:30 p.m., August 15, 2020.

As the model cold storage facility for the Minhai International Industrial Park project, this undertaking sets a high overall standard. It offers comprehensive functionality, reliable quality, timely completion, stable operation, and convenient maintenance. It is equipped with features such as one‑in‑one‑out redundancy, dual‑circuit power supply, automatic failover, automated control, alarm systems, and a mobile app.

Hereby announced!

 

 

Beijing Minhai Biotechnology Co., Ltd.

August 1, 2020

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09